N※N

MannKind to Present at the Citi 2011 Global Healthcare Conference

  //health-fitness.news-articles.net/content/2011/ .. -the-citi-2011-global-healthcare-conference.html
  Published in Health and Fitness on Tuesday, February 22nd 2011 at 15:15 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

VALENCIA, Calif.--([ BUSINESS WIRE ])--MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Citi 2011 Global Healthcare Conference on Tuesday, March 1, 2011 at 2:30 PM (ET) at the Hilton New York in New York, New York.

Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Company's website at [ http://www.mannkindcorp.com ].

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its lead product candidate, AFREZZA^(R), is in late stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind is also evaluating an investigational cancer immunotherapy product, MKC1106-MT, in a phase 2 clinical trial. MannKind maintains a website at [ http://www.mannkindcorp.com ] to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.